Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bionest Partners and Scisive Consulting Merge

Published: Tuesday, January 29, 2013
Last Updated: Tuesday, January 29, 2013
Bookmark and Share
The merged companies will operate under the name of Bionest Partners with offices in New York, Paris, London and San Diego, with presence in Munich and Tokyo.

Success in today’s competitively evolved medical industry requires insightful strategy informed by operating practicalities. Bionest Partners has combined with Scisive Consulting to create a new model consulting firm intensely responsive to, and highly qualified for, the planning needs of a new generation of medical business leaders and investors. This fusion of two highly-respected medical business consultancies equips us to deal with the new demands of the medical marketplace, and also enables each to augment its intellectual capital and expand its geographic coverage.

Bionest Partners’ new senior management team will be Alain J. Gilbert and Bob J. Easton, as Co-Chair, together with partners Dr. Mary Koto, Catharine Staughton, Olivier Lesueur and Dr. Sean Hu, offering:

•    Complementarity of leadership, at once Strategic with Bob J. Easton and Operational with Alain J. Gilbert, to guarantee our clients "Practical Operability" of our recommendations
•    Broader sector and deeper functional expertise: drugs/devices/diagnostics (including personalized medicine); research/development/marketing/planning/pricing/corporate development
•    Personalized Medicine Strategy, widely recognized consulting expertise
•    Geographic reach, with offices in Paris, London, New York, San Diego and affiliates in Munich and Tokyo

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos